Coordination Group for Mutual Recognition and Decentralised Procedures – Human
E130564
The Coordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) is a European regulatory body that coordinates and oversees the mutual recognition and decentralised approval of human medicines across EU member states.
All labels observed (2)
How this entity was disambiguated
This entity first appeared as the object of triple T1143399 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Coordination Group for Mutual Recognition and Decentralised Procedures – Human Context triple: [Heads of Medicines Agencies, hasCommittee, Coordination Group for Mutual Recognition and Decentralised Procedures – Human]
-
A.
The Hague Working Group
The Hague Working Group is a subsidiary body of the International Criminal Court’s Assembly of States Parties that conducts detailed, ongoing negotiations and consultations on the Court’s governance, budget, and policy issues.
-
B.
Committee on Economic, Social and Cultural Rights
The Committee on Economic, Social and Cultural Rights is a body of independent experts that monitors and interprets states’ implementation of the International Covenant on Economic, Social and Cultural Rights within the UN human rights system.
-
C.
Global Alliance of National Human Rights Institutions
The Global Alliance of National Human Rights Institutions is an international network that supports, coordinates, and accredits national human rights institutions to promote and protect human rights worldwide.
-
D.
Working Group on Evaluations and Compliance
The Working Group on Evaluations and Compliance is a specialized body within the Financial Action Task Force responsible for assessing countries’ adherence to global anti–money laundering and counter-terrorist financing standards.
-
E.
Committee on the Rights of Persons with Disabilities
The Committee on the Rights of Persons with Disabilities is a United Nations expert body that monitors and guides implementation of the Convention on the Rights of Persons with Disabilities by its State Parties.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Coordination Group for Mutual Recognition and Decentralised Procedures – Human Target entity description: The Coordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) is a European regulatory body that coordinates and oversees the mutual recognition and decentralised approval of human medicines across EU member states.
-
A.
The Hague Working Group
The Hague Working Group is a subsidiary body of the International Criminal Court’s Assembly of States Parties that conducts detailed, ongoing negotiations and consultations on the Court’s governance, budget, and policy issues.
-
B.
Committee on Economic, Social and Cultural Rights
The Committee on Economic, Social and Cultural Rights is a body of independent experts that monitors and interprets states’ implementation of the International Covenant on Economic, Social and Cultural Rights within the UN human rights system.
-
C.
Global Alliance of National Human Rights Institutions
The Global Alliance of National Human Rights Institutions is an international network that supports, coordinates, and accredits national human rights institutions to promote and protect human rights worldwide.
-
D.
Working Group on Evaluations and Compliance
The Working Group on Evaluations and Compliance is a specialized body within the Financial Action Task Force responsible for assessing countries’ adherence to global anti–money laundering and counter-terrorist financing standards.
-
E.
Committee on the Rights of Persons with Disabilities
The Committee on the Rights of Persons with Disabilities is a United Nations expert body that monitors and guides implementation of the Convention on the Rights of Persons with Disabilities by its State Parties.
- F. None of above. chosen
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
European Union regulatory body
ⓘ
coordination group ⓘ medicines regulatory body ⓘ |
| abbreviation | CMDh ⓘ |
| abbreviationOfCounterpart | CMDv ⓘ |
| aimsTo |
harmonise the approval of human medicines across EU Member States
ⓘ
resolve disagreements between Member States in mutual recognition and decentralised procedures ⓘ |
| benefits |
patients in the European Union
ⓘ
pharmaceutical companies seeking multi-state authorisation ⓘ |
| collaboratesWith |
Committee for Medicinal Products for Human Use
ⓘ
European Commission ⓘ |
| composedOf |
representatives of EEA-EFTA states
ⓘ
representatives of EU Member States ⓘ |
| coordinates |
decentralised procedures for human medicines
ⓘ
mutual recognition procedures for human medicines ⓘ |
| ensures | consistent application of EU pharmaceutical legislation in MRP and DCP ⓘ |
| establishedFor | coordination of non-centralised EU marketing authorisation routes ⓘ |
| focusesOn |
coordination of decentralised marketing authorisation procedures
ⓘ
mutual recognition of national marketing authorisations ⓘ |
| hasCounterpart | Coordination Group for Mutual Recognition and Decentralised Procedures – Veterinary ⓘ |
| issues |
guidance on decentralised procedures
ⓘ
guidance on mutual recognition procedures ⓘ |
| jurisdiction |
European Economic Area
ⓘ
European Union ⓘ |
| language | English ⓘ |
| locatedIn | European Union ⓘ |
| meets | regularly according to an annual work plan ⓘ |
| memberOf |
European medicines regulatory authorities
ⓘ
surface form:
European medicines regulatory network
|
| oversees |
decentralised procedures for human medicines
ⓘ
mutual recognition procedures for human medicines ⓘ |
| parentBody |
Heads of Medicines Agencies
ⓘ
surface form:
Heads of Medicines Agencies network
|
| publishes |
lists of ongoing and finalised procedures
ⓘ
procedural advice for applicants ⓘ |
| regulates | marketing authorisation procedures for human medicines ⓘ |
| regulatoryProcessStage | post-centralised authorisation alternatives ⓘ |
| regulatoryScope | human medicines ⓘ |
| sector |
pharmaceuticals
ⓘ
public health ⓘ |
| subjectArea |
marketing authorisation of medicines
ⓘ
pharmaceutical regulation ⓘ |
| supports | implementation of EU pharmaceutical legislation ⓘ |
| topic |
coordination of regulatory decisions among Member States
ⓘ
mutual recognition of benefit–risk evaluations of medicines ⓘ |
| typeOfProcedureHandled |
Decentralised Procedure
ⓘ
Mutual Recognition Procedure ⓘ |
| website | https://www.hma.eu/cmdh.html ⓘ |
| worksWith |
European Medicines Agency
ⓘ
national competent authorities of EU Member States ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Coordination Group for Mutual Recognition and Decentralised Procedures – Human Description of subject: The Coordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) is a European regulatory body that coordinates and oversees the mutual recognition and decentralised approval of human medicines across EU member states.
Referenced by (4)
Full triples — surface form annotated when it differs from this entity's canonical label.